Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial
Criner et al., American Journal of Respiratory and Critical Care Medicine, doi:10.1164/rccm.202108-1859OC
https://c19early.org/criner.html